Fierce Pharma

Patients and providers often enter the exam room misaligned. A [...]

In a letter inked to the U.K.’s Competition and Markets [...]

The FDA has approved Jazz Pharmaceuticals’ Zepzelca, used in combination [...]

Vaxcyte is paying Thermo Fisher Scientific up to $1 billion [...]

The FDA agreed to re-review Vanda’s previously rejected bid to [...]

In the phase 3 Vesalius-CV study, Repatha helped significantly curb [...]

In a merger between two subcutaneous drug delivery companies, Halozyme [...]

In the latest instance of pharma tariff whiplash, the import [...]

The Sept. 29 settlement was the result of an investigation [...]

South Korea-based Boryung Corporation is boosting its global oncology foothold [...]